Share This Page
Medigrowth Australia  Logo

Medigrowth: Medicine re-imagined with medicinal cannabis

Personal Care & Healthcare

Victoria, Australia

Offer

CSF

Pre-Series A

$1,597,325.30

raised by 852 investors

Min target

Minimum target hit!

CLOSED ON

13 March 2025

Overview

Quality medicinal cannabis, research & development

​​Medigrowth is an innovative medicinal cannabis biotech company. We distribute our medicinal products (THC, CBD & dry flower) via multiple channels including our telehealth platform Haiku.Health.

We have delivered our Medigrowth products to thousands of Australian patients, nationwide, seeing YoY average revenue grow by 1200%. Our Deakin University collaboration provides us world-class resources and medical expertise.

Exciting clinical trial results with Medigrowth CBD highlight our commitment to evidence-based medicines. We're dedicated to improving lives for those with chronic health issues & with big plans ahead, we're ready to scale & make an even greater impact.

Meet the team

Directors

Sales & Marketing

Operations & Support

Advisors